Company intelligence / Profile preview

MITRE Corporation

McLean, Virginia, United Statesmitremedical.com ↗

Ownership: Private
Employees: ~9000
Development stage: Preclinical

Overview

MITRE leads federally funded research to improve U.S. healthcare systems by developing digital tools like Synthea for synthetic patient data generation and supporting federal agencies with analysis/policy recommendations. During COVID-19 it played a key role in supply chain innovation and rapid response infrastructure.

Therapeutic areas: Metabolic DisordersInfectious DiseasesOncologyWomen's Health
Modalities: DeviceSoftwareData analyticsArtificial intelligence (AI)Digital health technologies
Industry: Academic Hospital/University/Research

Drug pipeline

1 asset

Mitral Touch

Pre-clinical

Indications: Mitral valve regurgitation, Left ventricle remodeling

Partnerships

Mayo ClinicMicrosoftAmerican Society of Clinical Oncology

Beyond the preview

Go deeper on MITRE Corporation.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MITRE Corporation.

Explore the full profile